Cargando…

RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5

The small GTPase Ras-related C3 botulinum toxin substrate 1B (RAC1B) has been shown previously by RNA interference-mediated knockdown (KD) to function as a powerful inhibitor of transforming growth factor (TGF)-β1-induced cell migration and epithelial-mesenchymal transition in epithelial cells, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungefroren, Hendrik, Otterbein, Hannah, Fiedler, Christian, Mihara, Koichiro, Hollenberg, Morley D., Gieseler, Frank, Lehnert, Hendrik, Witte, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562819/
https://www.ncbi.nlm.nih.gov/pubmed/31108998
http://dx.doi.org/10.3390/cancers11050691
_version_ 1783426410550919168
author Ungefroren, Hendrik
Otterbein, Hannah
Fiedler, Christian
Mihara, Koichiro
Hollenberg, Morley D.
Gieseler, Frank
Lehnert, Hendrik
Witte, David
author_facet Ungefroren, Hendrik
Otterbein, Hannah
Fiedler, Christian
Mihara, Koichiro
Hollenberg, Morley D.
Gieseler, Frank
Lehnert, Hendrik
Witte, David
author_sort Ungefroren, Hendrik
collection PubMed
description The small GTPase Ras-related C3 botulinum toxin substrate 1B (RAC1B) has been shown previously by RNA interference-mediated knockdown (KD) to function as a powerful inhibitor of transforming growth factor (TGF)-β1-induced cell migration and epithelial-mesenchymal transition in epithelial cells, but the underlying mechanism has remained enigmatic. Using pancreatic carcinoma cells, we show that both KD and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-mediated knockout (KO) of RAC1B increased the expression of the TGF-β type I receptor ALK5 (activin receptor-like kinase 5), but this effect was more pronounced in CRISPR-KO cells. Of note, in KO, but not KD cells, ALK5 upregulation was associated with resensitization of TGFBR1 to induction by TGF-β1 stimulation. RAC1B KO also increased TGF-β1-induced C-terminal SMAD3 phosphorylation, SMAD3 transcriptional activity, growth inhibition, and cell migration. The KD of ALK5 expression by RNA interference or inactivation of the ALK5 kinase activity by dominant-negative interference or ATP-competitive inhibition rescued the cells from the RAC1B KD/KO-mediated increase in TGF-β1-induced cell migration, whereas the ectopic expression of kinase-active ALK5 mimicked this RAC1B KD/KO effect. We conclude that RAC1B downregulates the abundance of ALK5 and SMAD3 signaling, thereby attenuating TGF-β/SMAD3-driven cellular responses, such as growth inhibition and cell motility.
format Online
Article
Text
id pubmed-6562819
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65628192019-06-17 RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5 Ungefroren, Hendrik Otterbein, Hannah Fiedler, Christian Mihara, Koichiro Hollenberg, Morley D. Gieseler, Frank Lehnert, Hendrik Witte, David Cancers (Basel) Article The small GTPase Ras-related C3 botulinum toxin substrate 1B (RAC1B) has been shown previously by RNA interference-mediated knockdown (KD) to function as a powerful inhibitor of transforming growth factor (TGF)-β1-induced cell migration and epithelial-mesenchymal transition in epithelial cells, but the underlying mechanism has remained enigmatic. Using pancreatic carcinoma cells, we show that both KD and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-mediated knockout (KO) of RAC1B increased the expression of the TGF-β type I receptor ALK5 (activin receptor-like kinase 5), but this effect was more pronounced in CRISPR-KO cells. Of note, in KO, but not KD cells, ALK5 upregulation was associated with resensitization of TGFBR1 to induction by TGF-β1 stimulation. RAC1B KO also increased TGF-β1-induced C-terminal SMAD3 phosphorylation, SMAD3 transcriptional activity, growth inhibition, and cell migration. The KD of ALK5 expression by RNA interference or inactivation of the ALK5 kinase activity by dominant-negative interference or ATP-competitive inhibition rescued the cells from the RAC1B KD/KO-mediated increase in TGF-β1-induced cell migration, whereas the ectopic expression of kinase-active ALK5 mimicked this RAC1B KD/KO effect. We conclude that RAC1B downregulates the abundance of ALK5 and SMAD3 signaling, thereby attenuating TGF-β/SMAD3-driven cellular responses, such as growth inhibition and cell motility. MDPI 2019-05-17 /pmc/articles/PMC6562819/ /pubmed/31108998 http://dx.doi.org/10.3390/cancers11050691 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ungefroren, Hendrik
Otterbein, Hannah
Fiedler, Christian
Mihara, Koichiro
Hollenberg, Morley D.
Gieseler, Frank
Lehnert, Hendrik
Witte, David
RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
title RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
title_full RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
title_fullStr RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
title_full_unstemmed RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
title_short RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
title_sort rac1b suppresses tgf-β1-dependent cell migration in pancreatic carcinoma cells through inhibition of the tgf-β type i receptor alk5
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562819/
https://www.ncbi.nlm.nih.gov/pubmed/31108998
http://dx.doi.org/10.3390/cancers11050691
work_keys_str_mv AT ungefrorenhendrik rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT otterbeinhannah rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT fiedlerchristian rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT miharakoichiro rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT hollenbergmorleyd rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT gieselerfrank rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT lehnerthendrik rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5
AT wittedavid rac1bsuppressestgfb1dependentcellmigrationinpancreaticcarcinomacellsthroughinhibitionofthetgfbtypeireceptoralk5